PWM
BMY icon

Proathlete Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Proathlete Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.4K Hold
930
– – 0.02% 111
2025
Q4 		$50.2K Sell
930
-1,506
-62% -$72.4K 0.01% 122
2025
Q3 		$110K Hold
2,436
– – 0.03% 91
2025
Q2 		$113K Hold
2,436
– – 0.04% 89
2025
Q1 		$149K Buy
+2,436
New +$142K 0.05% 69

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Proathlete Wealth Management's BMY Position: Q1 2026 in Review

Proathlete Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 930 shares worth $56.4K. The position accounts for 0.02% of the portfolio, ranked #111.

Proathlete Wealth Management first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $149K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Proathlete Wealth Management held 930 shares of Bristol-Myers Squibb worth $56.4K as of Q1 2026.
  • Proathlete Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of Proathlete Wealth Management's portfolio in Q1 2026, its #111 holding.
  • Proathlete Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • Proathlete Wealth Management's Bristol-Myers Squibb position peaked at $149K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Proathlete Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.